Tyr514
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr514  -  PKCD (human)

Site Information
tFCGtPDyIAPEILQ   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 450078

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 3 ) , phospho-antibody ( 2 ) , western blotting ( 2 )
Disease tissue studied:
lymphoma ( 1 ) , Burkitt's lymphoma ( 1 ) , follicular lymphoma ( 1 ) , mantle cell lymphoma ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Regulatory protein:
FAS (human) ( 2 ) , PKCD (human) ( 2 )
Treatments:
free_fatty_acids ( 2 )

References 

1

Rolland D, et al. (2014) Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas. Am J Pathol 184, 1331-42
24667141   Curated Info

2

Yang F, Cai W, Yang K, Chen M (2013) PKCĪ“ knockdown inhibits free fatty acid induction of endothelial cell apoptosis. Cell Biochem Funct 31, 380-4
23086745   Curated Info

3

Rikova K (2012) CST Curation Set: 13733; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 2/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info